Evaxion presents preclinical data on AML vaccine candidate
AI Summary
Evaxion has presented preclinical data on a vaccine candidate targeting acute myeloid leukemia (AML), advancing its research in immunotherapy treatments for cancer.
Evaxion has presented preclinical data on a vaccine candidate targeting acute myeloid leukemia (AML), advancing its research in immunotherapy treatments for cancer.
The Straits Times —
Globo —
Die Welt —
Punch Nigeria —
Yonhap News —
Globo —